POPULATION OF INTEREST

All patients exposed to biological exposure/injury

DATA  SOURCE

PERFORMANCE/ADHERENCE  MEASURES

  1. Recognition of clinical syndrome
  2. Appropriate use of broad spectrum MCM
  3. Broad spectrum MCM changed to narrow spectrum MCM (if applicable).
  4. Appropriate route, dose and administration of MCM
  5. Definitive clinical laboratory confirmation of biothreat
  6. Recognition of an outbreak (if applicable)
  7. Technical reach-back utilized

INTENT  (EXPECTED  OUTCOMES)

Reduction of morbidity and mortality from biothreats.

SYSTEM  REPORTING  &  FREQUENCY

The above constitutes the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually. Additional PI monitoring and system reporting may be performed as needed.

The system review and data analysis will be performed by the JTS Chief, JTS Program Manager and the JTS PI Branch.

RESPONSIBILITIES

It is the clinical team leader’s responsibility to ensure familiarity, appropriate compliance, and PI monitoring at the local level with this CPG.